KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $7.39 million. The enterprise value is $16.24 million.

Market Cap	7.39M
Enterprise Value	16.24M

Important Dates

The last earnings date was Wednesday, November 19, 2025, before market open.

Earnings Date	Nov 19, 2025
Ex-Dividend Date	n/a

Share Statistics

KALA BIO has 8.21 million shares outstanding. The number of shares has increased by 86.46% in one year.

Current Share Class	8.21M
Shares Outstanding	8.21M
Shares Change (YoY)	+86.46%
Shares Change (QoQ)	+8.13%
Owned by Insiders (%)	0.68%
Owned by Institutions (%)	39.76%
Float	8.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.75

Current Ratio	0.75
Quick Ratio	0.65
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-65.81%
Return on Invested Capital (ROIC)	-79.87%
Return on Capital Employed (ROCE)	551.34%
Revenue Per Employee	n/a
Profits Per Employee	-$943,184
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.53% in the last 52 weeks. The beta is -2.51, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y)	-2.51
52-Week Price Change	-86.53%
50-Day Moving Average	1.38
200-Day Moving Average	5.53
Relative Strength Index (RSI)	40.65
Average Volume (20 Days)	20,498,786

Short Selling Information

The latest short interest is 464,411, so 5.66% of the outstanding shares have been sold short.

Short Interest	464,411
Short Previous Month	695,723
Short % of Shares Out	5.66%
Short % of Float	5.70%
Short Ratio (days to cover)	0.94

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.64M
Pretax Income	-35.84M
Net Income	-35.84M
EBITDA	-41.31M
EBIT	-41.64M
Earnings Per Share (EPS)	-$5.83

Full Income Statement

Balance Sheet

The company has $21.10 million in cash and $29.94 million in debt, giving a net cash position of -$8.85 million or -$1.08 per share.

Cash & Cash Equivalents	21.10M
Total Debt	29.94M
Net Cash	-8.85M
Net Cash Per Share	-$1.08
Equity (Book Value)	-8.67M
Book Value Per Share	-1.17
Working Capital	-8.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.03 million and capital expenditures -$84,000, giving a free cash flow of -$32.12 million.

Operating Cash Flow	-32.03M
Capital Expenditures	-84,000
Free Cash Flow	-32.12M
FCF Per Share	-$3.91

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-86.46%
Shareholder Yield	-86.46%
Earnings Yield	-485.08%
FCF Yield	-434.67%

Analyst Forecast

The average price target for KALA BIO is $31.50, which is 3,400.00% higher than the current price. The consensus rating is "Buy".

Price Target	$31.50
Price Target Difference	3,400.00%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	1:50

Scores

Altman Z-Score	n/a
Piotroski F-Score	1